Log in

Good pharmacovigilance practices (GVP) are a set of Measures drawn up to Facilitate the performance of pharmacovigilance in the European Union (EU). GVP apply to marketing permission-holders, the European Medicines Agency and medicines regulatory autorités in EU Member States. They cover medicines authorized centrally via the Agency as well as medicines authorized at national level.

Good Pharmacovigilance Practices (GVP)

a3p-100pxhaut logo


Commit to share
Transmit and progress together
Promoting innovation

The A3P Association is a major player in the pharmaceutical and biotechnology industry.
Created in 1986, it contributes to the good development of the production of medicines and clean and sterile equipment, it runs a network of professionals 21 000, manufacturers and suppliers, as part of International Congress and technical days.

It now has over 1700 members who share their technical experience, scientific and regulatory.

More info on video (Versiongb - drapeauitalie )

  group    administrators A3P
& Project Managers

letter   newsletter A3P